$TBPH
Theravance Biopharma Inc

2018 Q4 Form 10-K Financial Statement

#000155837020001644 Filed on February 27, 2020

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2018 Q2
Revenue $15.74M $12.84M $23.48M
YoY Change 249.71% 198.56% 570.74%
Cost Of Revenue $600.0K $700.0K -$1.400M
YoY Change -80.65% -30.0% -200.0%
Gross Profit $15.10M $12.10M $24.90M
YoY Change 978.57% 266.67% 1085.71%
Gross Profit Margin 95.95% 94.25% 106.07%
Selling, General & Admin $25.50M $21.89M $25.01M
YoY Change -13.56% 4.74% 2.91%
% of Gross Profit 168.87% 180.91% 100.43%
Research & Development $52.30M $52.69M $48.62M
YoY Change 2.35% 34.08% 13.34%
% of Gross Profit 346.36% 435.48% 195.27%
Depreciation & Amortization $860.0K $620.0K $790.0K
YoY Change -15.69% -34.74% -19.39%
% of Gross Profit 5.7% 5.12% 3.17%
Operating Expenses $78.36M $75.29M $72.18M
YoY Change -2.78% 24.86% 7.41%
Operating Profit -$62.62M -$62.45M -$48.70M
YoY Change -20.93% 9.56% -25.19%
Interest Expense $9.200M $2.137M $2.137M
YoY Change -1250.0% -313.7% -405.29%
% of Operating Profit
Other Income/Expense, Net $1.376M $1.284M
YoY Change
Pretax Income -$53.40M -$60.09M -$47.61M
YoY Change -33.17% -8.95% -27.65%
Income Tax -$3.300M -$659.0K -$6.790M
% Of Pretax Income
Net Earnings -$50.19M -$59.43M -$40.82M
YoY Change -42.25% -11.16% -38.43%
Net Earnings / Revenue -318.9% -462.95% -173.87%
Basic Earnings Per Share
Diluted Earnings Per Share -$919.4K -$1.096M -$758.4K
COMMON SHARES
Basic Shares Outstanding 55.23M 54.96M
Diluted Shares Outstanding 54.25M 53.80M

Balance Sheet

Concept 2018 Q4 2018 Q3 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $505.3M $300.4M $352.9M
YoY Change 44.94% -10.33% -2.46%
Cash & Equivalents $378.0M $101.2M $103.9M
Short-Term Investments $127.3M $199.2M $249.0M
Other Short-Term Assets $16.90M $7.300M $8.600M
YoY Change 322.5% 92.11% 100.0%
Inventory $0.00 $17.90M $17.90M
Prepaid Expenses
Receivables $620.0K $6.900M $7.300M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $532.8M $332.6M $386.7M
YoY Change 40.7% -9.4% 0.47%
LONG-TERM ASSETS
Property, Plant & Equipment $13.18M $12.40M $10.70M
YoY Change 29.18% 44.19% 22.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $11.90M $20.20M $18.30M
YoY Change -71.39% -79.68% -87.33%
Other Assets $1.534M $2.600M $2.600M
YoY Change -43.19% -10.34% -55.93%
Total Long-Term Assets $27.41M $38.40M $34.70M
YoY Change -56.28% -67.76% -78.18%
TOTAL ASSETS
Total Short-Term Assets $532.8M $332.6M $386.7M
Total Long-Term Assets $27.41M $38.40M $34.70M
Total Assets $560.2M $371.0M $421.4M
YoY Change 26.92% -23.69% -22.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.028M $3.700M $3.600M
YoY Change 53.02% -33.93% -43.75%
Accrued Expenses $46.10M $41.00M $35.40M
YoY Change -18.41% -4.65% -30.04%
Deferred Revenue $43.40M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $98.55M $102.0M $93.50M
YoY Change 57.43% 109.02% 63.75%
LONG-TERM LIABILITIES
Long-Term Debt $454.4M $224.6M $224.3M
YoY Change 103.13% 0.49% 0.49%
Other Long-Term Liabilities $24.76M $57.80M $69.20M
YoY Change -37.94% 93.96% 208.93%
Total Long-Term Liabilities $24.76M $282.4M $293.5M
YoY Change -90.61% 11.49% 19.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $98.55M $102.0M $93.50M
Total Long-Term Liabilities $24.76M $282.4M $293.5M
Total Liabilities $123.3M $384.4M $387.0M
YoY Change -62.2% 27.28% 27.81%
SHAREHOLDERS EQUITY
Retained Earnings -$1.012B
YoY Change
Common Stock $1.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$51.59M -$13.45M $34.39M
YoY Change
Total Liabilities & Shareholders Equity $560.2M $371.0M $421.4M
YoY Change 26.92% -23.69% -22.52%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2018 Q2
OPERATING ACTIVITIES
Net Income -$50.19M -$59.43M -$40.82M
YoY Change -42.25% -11.16% -38.43%
Depreciation, Depletion And Amortization $860.0K $620.0K $790.0K
YoY Change -15.69% -34.74% -19.39%
Cash From Operating Activities -$52.18M -$48.98M -$61.54M
YoY Change 18.05% -21.38% 38.23%
INVESTING ACTIVITIES
Capital Expenditures -$1.500M -$1.870M -$1.100M
YoY Change 476.92% 128.05% 48.65%
Acquisitions
YoY Change
Other Investing Activities $100.9M $48.53M $43.05M
YoY Change 143.11% 211.29% 261.16%
Cash From Investing Activities $99.39M $46.65M $41.96M
YoY Change 140.95% 215.84% 275.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 229.6M -320.0K -2.400M
YoY Change 36344.44% -58.97% -179.21%
NET CHANGE
Cash From Operating Activities -52.18M -48.98M -61.54M
Cash From Investing Activities 99.39M 46.65M 41.96M
Cash From Financing Activities 229.6M -320.0K -2.400M
Net Change In Cash 276.8M -2.650M -21.98M
YoY Change -12031.47% -94.51% -27.51%
FREE CASH FLOW
Cash From Operating Activities -$52.18M -$48.98M -$61.54M
Capital Expenditures -$1.500M -$1.870M -$1.100M
Free Cash Flow -$50.68M -$47.11M -$60.44M
YoY Change 15.34% -23.37% 38.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
George Town, Grand Cayman
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55681000
CY2019 dei Entity Address Country
EntityAddressCountry
KY
CY2019 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
KY1-1104
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57015000
CY2019 dei City Area Code
CityAreaCode
650
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2018Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2019Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2018Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2019Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2019Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OperatingLeaseRightOfUseAsset
CY2019Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherAccruedLiabilitiesCurrent
CY2019Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OperatingLeaseLiabilityNoncurrent
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001583107
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2019 dei Entity File Number
EntityFileNumber
001-36033
CY2019 dei Entity Registrant Name
EntityRegistrantName
THERAVANCE BIOPHARMA, INC.
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
KY
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1226628
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
P.O. Box 309
CY2019 dei Entity Address Address Line2
EntityAddressAddressLine2
Ugland House, South Church Street
CY2019 dei Local Phone Number
LocalPhoneNumber
808-6000
CY2019 dei Security12b Title
Security12bTitle
Ordinary Share $0.00001 Par Value
CY2019 dei Trading Symbol
TradingSymbol
TBPH
CY2019 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q4 tbph Receivables From Licensing Arrangements
ReceivablesFromLicensingArrangements
10000000
CY2019Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
28574000
CY2018Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
5422000
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
7087000
CY2019 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2019 dei Entity Small Business
EntitySmallBusiness
false
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019Q2 dei Entity Public Float
EntityPublicFloat
893464384
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
62520148
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
127255000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58064000
CY2018Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
11452000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
338488000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Assets Current
AssetsCurrent
532823000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12644000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
378021000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
222767000
CY2018Q4 tbph Receivables From Collaboration Partners
ReceivablesFromCollaborationPartners
10053000
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
5659000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
620000
CY2019Q4 tbph Receivables From Collaboration Partners
ReceivablesFromCollaborationPartners
11996000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13176000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
4985000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
11869000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
46604000
CY2019Q4 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
3682000
CY2019Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
833000
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
833000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1590000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1534000
CY2019Q4 us-gaap Assets
Assets
408826000
CY2018Q4 us-gaap Assets
Assets
560235000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4758000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9028000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
28180000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
23803000
CY2019Q4 tbph Accrued Clinical And Development Expenses Current
AccruedClinicalAndDevelopmentExpensesCurrent
17587000
CY2018Q4 tbph Accrued Clinical And Development Expenses Current
AccruedClinicalAndDevelopmentExpensesCurrent
11876000
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
3086000
CY2019Q4 tbph Non Recourse Debt Current
NonRecourseDebtCurrent
9851000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7762000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
31575000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
43402000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6331000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7359000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
111703000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
98554000
CY2019Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
225890000
CY2018Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
224818000
CY2019Q4 tbph Non Recourse Debt Noncurrent
NonRecourseDebtNoncurrent
219300000
CY2018Q4 tbph Non Recourse Debt Noncurrent
NonRecourseDebtNoncurrent
229535000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
7976000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
47725000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
6761000
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
26179000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
21287000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
24762000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
230000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
230000
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57015000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55681000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1024614000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
960721000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
145000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-166000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1248600000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1012145000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-223840000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-51589000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
408826000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
560235000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73414000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
60370000
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15386000
CY2018 tbph Adjusted Cost Of Goods And Services Sold
AdjustedCostOfGoodsAndServicesSold
715000
CY2017 tbph Adjusted Cost Of Goods And Services Sold
AdjustedCostOfGoodsAndServicesSold
6030000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
219248000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
201348000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
173887000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
106081000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
97058000
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
95592000
CY2019 us-gaap Operating Expenses
OperatingExpenses
325329000
CY2018 us-gaap Operating Expenses
OperatingExpenses
299121000
CY2017 us-gaap Operating Expenses
OperatingExpenses
275509000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-251915000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-238751000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-260123000
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
33705000
CY2018 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
11182000
CY2017 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
170000
CY2019 us-gaap Interest Expense
InterestExpense
31862000
CY2018 us-gaap Interest Expense
InterestExpense
10482000
CY2017 us-gaap Interest Expense
InterestExpense
8547000
CY2017 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
8000000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8395000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11966000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4789000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-241677000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-226085000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-271711000
CY2018 tbph Amortization And Accretion Income
AmortizationAndAccretionIncome
1315000
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.99
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.45
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
49175000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6236000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5222000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10561000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13694000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-236455000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-215524000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-285405000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.25
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55610000
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
53969000
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
52352000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
60450000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
51313000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
49145000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-236455000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-215524000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-285405000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
311000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
567000
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-480000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-236144000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-214957000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-285885000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
350231000
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1000
CY2017 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3980000
CY2017 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
8560000
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-480000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-285405000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
115178000
CY2018 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
4173000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
51313000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1393000
CY2018 us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
1119000
CY2018 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
9808000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
567000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-215524000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-51589000
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3474000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
60450000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3142000
CY2019 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3173000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
311000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-236455000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-223840000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-236455000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-215524000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-285405000
CY2019 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
6441000
CY2018 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
4481000
CY2017 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
3801000
CY2019 tbph Amortization And Accretion Income
AmortizationAndAccretionIncome
3451000
CY2017 tbph Amortization And Accretion Income
AmortizationAndAccretionIncome
-226000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
60450000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
51313000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
49145000
CY2018 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
6056000
CY2017 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
8000000
CY2017 us-gaap Inventory Write Down
InventoryWriteDown
740000
CY2019 tbph Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
3224000
CY2019 tbph Equity Method Investments Undistributed Earnings
EquityMethodInvestmentsUndistributedEarnings
23152000
CY2018 tbph Equity Method Investments Undistributed Earnings
EquityMethodInvestmentsUndistributedEarnings
5152000
CY2019 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-146000
CY2018 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
43000
CY2017 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-10000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-620000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1633000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1607000
CY2019 tbph Increase Decrease In Receivables From Collaboration Partners
IncreaseDecreaseInReceivablesFromCollaborationPartners
11943000
CY2018 tbph Increase Decrease In Receivables From Collaboration Partners
IncreaseDecreaseInReceivablesFromCollaborationPartners
2944000
CY2017 tbph Increase Decrease In Receivables From Collaboration Partners
IncreaseDecreaseInReceivablesFromCollaborationPartners
-1967000
CY2017 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-2788000
CY2019 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
634000
CY2018 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
2400000
CY2017 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
1489000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1629000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7301000
CY2019 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
3700000
CY2018 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-8191000
CY2017 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
7890000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
358000
CY2018 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-45000
CY2017 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
354000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4274000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3575000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3796000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
10626000
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-12357000
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
8332000
CY2019 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2573000
CY2018 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1841000
CY2017 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
21000
CY2018 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-4308000
CY2017 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
298000
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-31245000
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
69224000
CY2017 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
17000
CY2019 tbph Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2317000
CY2019 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-4748000
CY2018 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-10058000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6236000
CY2017 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4929000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
49847000
CY2017 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
24449000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-238197000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-112867000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-201052000
CY2019 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3176000
CY2018 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
7240000
CY2017 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2406000
CY2019 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
423898000
CY2018 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
183261000
CY2017 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
288791000
CY2019 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
339018000
CY2018 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
347192000
CY2017 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
234864000
CY2019 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
5000000
CY2018 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
20000000
CY2019 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
5000
CY2018 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
17000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-83051000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
176708000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-56333000
CY2018 tbph Proceeds From Issuance Of Non Recourse Debt
ProceedsFromIssuanceOfNonRecourseDebt
229441000
CY2019 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2152000
CY2019 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
3474000
CY2018 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
4173000
CY2017 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
3980000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3142000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1393000
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3173000
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9807000
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8560000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1291000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
225200000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1656000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-319957000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
289041000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-255729000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
378854000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89813000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
345542000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58897000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
378854000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89813000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
26178000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
7475000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
7454000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
22000
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-7316000
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman';font-size:10pt;min-height:12.0pt;text-indent:36pt;margin:0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.</p>
CY2019 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
800000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
800000
CY2018 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
-362000
CY2018 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
-8027000
CY2018Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1528000
CY2019 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
199000
CY2019 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
-466000
CY2019Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1261000
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Concentration of Credit Risks</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;">The Company invests in a variety of financial instruments and, based on its policy, limits the amount of credit exposure with any one issuer, industry or geographic area for investments other than instruments backed by the US federal government. </p>
CY2017Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
2290000
CY2018 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
7627000
CY2019 tbph Change In Estimate Of Accrued Research As Percent Of Annual Expense
ChangeInEstimateOfAccruedResearchAsPercentOfAnnualExpense
0.01
CY2019 us-gaap Advertising Expense
AdvertisingExpense
2400000
CY2018 us-gaap Advertising Expense
AdvertisingExpense
1900000
CY2017 us-gaap Advertising Expense
AdvertisingExpense
3200000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
58800000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
52400000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-236455000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-215524000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-285405000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56452000
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55076000
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53703000
CY2019 tbph Incremental Common Shares Attributable To Dilutive Effect Of Common Share Subject To Forfeiture Incremental Common Shares Attributable To Dilutive Effect Of Common Share Subject To Forfeiture
IncrementalCommonSharesAttributableToDilutiveEffectOfCommonShareSubjectToForfeitureIncrementalCommonSharesAttributableToDilutiveEffectOfCommonShareSubjectToForfeiture
-842000
CY2018 tbph Incremental Common Shares Attributable To Dilutive Effect Of Common Share Subject To Forfeiture Incremental Common Shares Attributable To Dilutive Effect Of Common Share Subject To Forfeiture
IncrementalCommonSharesAttributableToDilutiveEffectOfCommonShareSubjectToForfeitureIncrementalCommonSharesAttributableToDilutiveEffectOfCommonShareSubjectToForfeiture
-1107000
CY2017 tbph Incremental Common Shares Attributable To Dilutive Effect Of Common Share Subject To Forfeiture Incremental Common Shares Attributable To Dilutive Effect Of Common Share Subject To Forfeiture
IncrementalCommonSharesAttributableToDilutiveEffectOfCommonShareSubjectToForfeitureIncrementalCommonSharesAttributableToDilutiveEffectOfCommonShareSubjectToForfeiture
-1351000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55610000
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53969000
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52352000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.25
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.99
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.45
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13253000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10170000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10051000
CY2019 tbph Collaborative Arrangement Research And Development Expenses Reimbursed To Entity
CollaborativeArrangementResearchAndDevelopmentExpensesReimbursedToEntity
5589000
CY2018 tbph Collaborative Arrangement Research And Development Expenses Reimbursed To Entity
CollaborativeArrangementResearchAndDevelopmentExpensesReimbursedToEntity
9112000
CY2017 tbph Collaborative Arrangement Research And Development Expenses Reimbursed To Entity
CollaborativeArrangementResearchAndDevelopmentExpensesReimbursedToEntity
23540000
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
454353000
CY2019 us-gaap Lease Practical Expedients Package
LeasePracticalExpedientsPackage
true
CY2019 us-gaap Lease Practical Expedient Use Of Hindsight
LeasePracticalExpedientUseOfHindsight
true
CY2019 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
31245000
CY2018 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
130000
CY2018Q1 tbph Profit Loss Percentage As Per Collaboration Agreement
ProfitLossPercentageAsPerCollaborationAgreement
0.33
CY2019 tbph Profit Loss Percentage As Per Collaboration Agreement
ProfitLossPercentageAsPerCollaborationAgreement
0.35
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73414000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
60370000
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15386000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58064000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
378021000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88980000
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
833000
CY2018Q4 us-gaap Restricted Cash
RestrictedCash
833000
CY2017Q4 us-gaap Restricted Cash
RestrictedCash
833000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58897000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
378854000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89813000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
274014000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
148000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
274159000
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
501837000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
8000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
174000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
501671000
CY2019 tbph Marketable Securities Maximum Contractual Maturity Period
MarketableSecuritiesMaximumContractualMaturityPeriod
P16M
CY2019 tbph Marketable Securities Average Contractual Maturity Period
MarketableSecuritiesAverageContractualMaturityPeriod
P3M
CY2018Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2018Q4 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
0
CY2019Q4 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
0
CY2015Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures Fair Value Disclosure
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure
8000000.0
CY2015Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures Fair Value Disclosure
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure
8000000.0
CY2017 us-gaap Impairment Of Investments
ImpairmentOfInvestments
8000000.0
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
455041000
CY2019 tbph Number Of Options To Extend
NumberOfOptionsToExtend
2
CY2019Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2019 us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
CY2019 tbph Number Of Options To Extend
NumberOfOptionsToExtend
2
CY2019 us-gaap Interest Expense Debt
InterestExpenseDebt
28811000
CY2018 us-gaap Interest Expense Debt
InterestExpenseDebt
9316000
CY2017 us-gaap Interest Expense Debt
InterestExpenseDebt
7475000
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3051000
CY2018 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1166000
CY2017 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1072000
CY2019 us-gaap Interest Expense
InterestExpense
31862000
CY2018 us-gaap Interest Expense
InterestExpense
10482000
CY2017 us-gaap Interest Expense
InterestExpense
8547000
CY2019Q4 tbph Area Of Leased Space
AreaOfLeasedSpace
170000
CY2019 tbph Number Of Building Leased
NumberOfBuildingLeased
2
CY2019Q4 tbph Tenant Improvement Allowance
TenantImprovementAllowance
15600000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
46604000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7762000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
47725000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
55487000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
10128000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7940000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
9480000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
9745000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
10023000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
10309000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
59860000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
107357000
CY2019Q4 tbph Tenant Improvement Allowance
TenantImprovementAllowance
15561000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
36309000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
55487000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
7200000
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y2M12D
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0865
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13694000
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0216
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0467
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0504
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5200000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10600000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13700000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
60212000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
62871000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
47568000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
49695000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12644000
CY2014Q2 tbph Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans
3
CY2019Q4 us-gaap Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries
DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries
0
CY2019Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
0
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13176000
CY2019 us-gaap Depreciation
Depreciation
3300000
CY2018 us-gaap Depreciation
Depreciation
3000000.0
CY2017 us-gaap Depreciation
Depreciation
2500000
CY2015Q3 tbph Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost Recognized
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCostRecognized
1400000
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2015Q3 tbph Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost Recognized
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCostRecognized
1400000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
60450000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
51313000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
49145000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
60450000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
51313000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
49145000
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
112908000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-241677000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-226085000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-271711000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-5222000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-10561000
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
13694000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5222000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-10561000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
58161000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
33396000
CY2019Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
19409000
CY2018Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
19409000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
15723000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
8508000
CY2019Q4 tbph Deferred Tax Assets Property Plant And Equipment And Intangible Assets
DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets
285341000
CY2018Q4 tbph Deferred Tax Assets Property Plant And Equipment And Intangible Assets
DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibleAssets
285821000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
15480000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
12479000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
8245000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
8343000
CY2019Q4 tbph Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
11358000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
7000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
413724000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
367956000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
403836000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
367748000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
9888000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
208000
CY2019Q4 tbph Deferred Tax Liabilities Operating Lease Assets
DeferredTaxLiabilitiesOperatingLeaseAssets
9429000
CY2019Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
459000
CY2018Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
208000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
9888000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
208000
CY2019Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
282700000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
367700000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
403800000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
41794000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
685000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
11295000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
52404000
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
2010000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
8369000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
58763000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
58800000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
52400000
CY2019 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-8000000.0
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017Q4 us-gaap Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit
12400000
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5338000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26150000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12427000
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29499000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
79004000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
68626000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
77628000
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
100071000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-40818000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-73666000
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.05
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-42476000
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15737000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
73295000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
72180000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
75288000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-65201000
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-70572000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-72580000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-39838000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-58431000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-65606000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.32
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.72
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
78358000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-64976000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-48704000
CY2019Q1 us-gaap Restructuring And Related Cost Expected Number Of Positions Eliminated
RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated
51
CY2019 us-gaap Severance Costs1
SeveranceCosts1
3500000
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.17
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8319000
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23476000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12838000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-62450000
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-62621000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-65087000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-50186000
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.22
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.76
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.10
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.92
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-59433000

Files In Submission

Name View Source Status
0001558370-20-001644-index-headers.html Edgar Link pending
0001558370-20-001644-index.html Edgar Link pending
0001558370-20-001644.txt Edgar Link pending
0001558370-20-001644-xbrl.zip Edgar Link pending
ex-10d67.htm Edgar Link pending
ex-10d67g001.jpg Edgar Link pending
ex-10d67g002.jpg Edgar Link pending
ex-10d68.htm Edgar Link pending
ex-21d1.htm Edgar Link pending
ex-23d1.htm Edgar Link pending
ex-31d1.htm Edgar Link pending
ex-31d2.htm Edgar Link pending
ex-32.htm Edgar Link pending
ex-4d10.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tbph-20191231.xsd Edgar Link pending
tbph-20191231x10kc43919.htm Edgar Link pending
tbph-20191231x10kc43919006.jpg Edgar Link pending
tbph-20191231x10kc43919008.jpg Edgar Link pending
tbph-20191231x10kc43919_htm.xml Edgar Link completed
tbph-20191231_cal.xml Edgar Link unprocessable
tbph-20191231_def.xml Edgar Link unprocessable
tbph-20191231_lab.xml Edgar Link unprocessable
tbph-20191231_pre.xml Edgar Link unprocessable